Y-3 for Injection in the Treatment of Acute Ischemic Stroke

NCT06517173 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

998

Enrollment

OTHER

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

DRUG: Y-3 for injection
DRUG: Placebo control group

Sponsor

Beijing Tiantan Hospital

Collaborators

[object Object]